Low Iron And Ferritin On TRT: What Blood Work Is Needed?
Timeline
Timestamp
Topic
00:00
A 53-year-old man on TRT presents low iron, very low ferritin, low-normal hemoglobin, and other laboratory results and asks whether he should be concerned and what additional blood work he needs.
02:37
Dr. O’Connor reviews the member’s CBC and explains why a hemoglobin of 13.1 is low-normal and unusual enough on testosterone to raise questions about phlebotomy, iron loss, and additional iron studies.
05:00
Low iron and ferritin lead to a discussion of excessive blood donation, thalassemia, gastrointestinal bleeding, and the importance of age-appropriate colonoscopy when the cause of iron loss is unclear.
08:45
Dr. O’Connor directly answers that the low iron and ferritin deserve attention and explains why repeated phlebotomy should not automatically be continued in a man whose red blood cell measurements are already low-normal.
13:56
The member’s testosterone regimen is reviewed, including his reduction from 200 mg weekly to approximately 120 mg and the importance of injection timing when interpreting testosterone levels during frequent dosing.
17:53
Dr. O’Connor broadens the discussion to ABCDs™ monitoring, including A1C, blood pressure, ApoB, LDL, HDL, cardiovascular screening, kidney protection, and prevention while remaining on testosterone.
Video Summary
A 53-year-old man on TRT asks whether low iron and ferritin require concern and additional testing. Dr. O’Connor reviews his hematocrit of 41.5%, hemoglobin of 13.1, very low ferritin, low iron, and history of testosterone therapy while questioning whether repeated blood donation or therapeutic phlebotomy may be depleting his iron stores.
The discussion explains why testosterone commonly increases red blood cell production and why unusually low iron and low-normal hemoglobin in a man on TRT deserve further evaluation rather than being dismissed. Dr. O’Connor discusses iron studies, CBC measurements, androgen-induced erythrocytosis, gastrointestinal blood loss, colonoscopy, and other possible explanations for iron depletion if excessive phlebotomy is not the cause.
Dr. O’Connor also reviews the member’s testosterone dose and injection schedule before expanding the discussion to long-term ABCDs™ monitoring. He emphasizes A1C, blood pressure, ApoB and other cholesterol markers, cardiovascular screening, kidney health, and age-appropriate cancer screening while encouraging men on testosterone to understand their laboratory data rather than focusing only on testosterone levels.
Drug Callouts
Drug
Description
Testosterone
The member has been on TRT for approximately one year and currently uses about 120 mg per week divided into three injections. Dr. O’Connor explains that testosterone commonly stimulates red blood cell production, making the member’s low iron, very low ferritin, and low-normal hemoglobin particularly important to investigate rather than assuming additional phlebotomy is needed.
Condition Callouts
Condition
Description
Iron Deficiency
The member has low serum iron and very low ferritin, indicating depleted iron stores that require an explanation. In men on testosterone, repeated phlebotomy used to manage rising hematocrit can contribute to iron depletion, but Dr. O’Connor stresses that other causes of blood or iron loss must also be considered.
Androgen-Induced Erythrocytosis
Dr. O’Connor specifically discusses androgen-induced erythrocytosis as the increase in red blood cell production that commonly occurs with testosterone therapy. He cautions that men on TRT may undergo unnecessary repeated phlebotomy when rising hemoglobin or hematocrit is treated too aggressively without considering the complete clinical picture.
Gastrointestinal Bleeding
Occult gastrointestinal blood loss is discussed as an alternative explanation for low iron and ferritin if excessive phlebotomy is not responsible. In a man on testosterone with unexpectedly depleted iron stores, Dr. O’Connor emphasizes investigating the source rather than assuming TRT management alone explains the laboratory findings.
Colorectal Cancer
Dr. O’Connor emphasizes age-appropriate colonoscopy because unexplained iron deficiency can sometimes reflect gastrointestinal blood loss from polyps or colorectal disease. For men on testosterone, routine preventive screening remains important even when laboratory abnormalities initially appear related to TRT.
Prediabetes And Type 2 Diabetes
Dr. O’Connor discusses A1C and glucose as part of the ABCDs™ framework and raises metabolic risk because of the member’s age and body weight. Men on testosterone still require close metabolic monitoring because TRT does not replace prevention and management of prediabetes or type 2 diabetes.
Coronary Artery Disease
Cardiovascular risk is discussed through HDL, LDL, ApoB, family history, and coronary calcium scoring. Dr. O’Connor notes that testosterone can lower HDL in some men and emphasizes evaluating the complete cardiovascular risk profile rather than relying on total cholesterol alone.
Key Takeaways
- Low iron and very low ferritin in a man on testosterone deserve evaluation because TRT more commonly increases red blood cell production rather than producing depleted iron stores.
- Repeated blood donation or therapeutic phlebotomy can deplete iron stores and should not automatically continue when hemoglobin and hematocrit are already low-normal.
- If excessive phlebotomy does not explain the iron deficiency, gastrointestinal blood loss and other medical causes should be investigated rather than assuming testosterone is responsible.
- CBC results should be interpreted together with ferritin, iron saturation, other iron studies, medical history, symptoms, and prior laboratory trends.
- Frequent testosterone injections still require attention to total weekly dose and laboratory timing because both factors affect interpretation of testosterone levels.
- Long-term TRT monitoring should extend beyond testosterone to A1C, blood pressure, ApoB and other lipids, kidney health, cardiovascular risk, and age-appropriate screening.